RAF1 and lung carcinoma: NNK has also been shown to activate the β2-adrenergic receptor, which transactivates the EGFR and Raf-1/ERK1/2 signaling cascades, both of which are also well characterized for their roles in lung cancer progression and metastasis (39, 40).